Want to see RVP full AI Analyst Report?
Top Page
Retractable Technologies
(NYSE MKT:RVP)
Select Model
Select Model
Rating:49Neutral
Price Target:
$0.72
▼(-1.92% Downside)
Action:Reiterated
Date:07/01/26
The score is primarily weighed down by weak financial performance (shrinking revenue, persistent losses, and negative operating/free cash flow), only partially cushioned by very low leverage. Technicals are modestly constructive in the near term but still below the 200-day trend, while valuation signals remain constrained by negative earnings and no provided common dividend yield. Corporate events are mixed, with restructuring risk offset by preferred dividend and stable board outcomes.
Positive Factors
Low leverage / balance sheet strength
Extremely low debt provides durable financial flexibility and reduces solvency risk, giving management runway to fund restructuring, invest selectively, or bridge cash shortfalls without immediate refinancing pressure. This buffer supports continuity while operating losses persist.
Negative Factors
Declining revenue and negative margins
Sustained top-line decline combined with deeply negative gross and net margins undermines scale economics and suggests weak pricing power or cost structure problems. If revenue contraction persists, fixed costs will pressure margins further and impede the path to sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / balance sheet strength
Extremely low debt provides durable financial flexibility and reduces solvency risk, giving management runway to fund restructuring, invest selectively, or bridge cash shortfalls without immediate refinancing pressure. This buffer supports continuity while operating losses persist.
Read all positive factors
Retractable Technologies (RVP) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$21.55M
Dividend YieldN/A
Average Volume (3M)153.51K
Price to Earnings (P/E)―
Beta (1Y)0.43
Revenue Growth10.08%
EPS Growth71.71%
CountryUS
Employees221
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-0.21
Shares Outstanding29,937,159
10 Day Avg. Volume341,920
30 Day Avg. Volume153,511
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)0.31
Price to Sales (P/S)0.60
P/FCF Ratio-3.04
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue0.49
Enterprise Value/Gross Profit247.36
Enterprise Value/Ebitda11.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Retractable Technologies Business Overview & Revenue Model
Company Description
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader ...
How the Company Makes Money
Retractable Technologies makes money primarily by selling its safety medical devices (especially retractable safety syringes and related injection/safety needle products) to healthcare customers through a mix of direct sales and distribution chann...
Retractable Technologies Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
72
Positive
Cash Flow
28
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.15M | 38.27M | 33.05M | 43.60M | 94.82M | 188.38M |
| Gross Profit | 73.59K | 47.05K | -1.03M | 9.11M | 28.25M | 95.35M |
| EBITDA | 1.59M | -4.42M | 4.17M | -1.24M | 9.94M | 76.44M |
| Net Income | -6.29M | -12.57M | -11.89M | -7.01M | 5.08M | 56.06M |
Balance Sheet | ||||||
| Total Assets | 137.60M | 142.63M | 160.72M | 179.67M | 210.74M | 213.15M |
| Cash, Cash Equivalents and Short-Term Investments | 35.62M | 36.97M | 44.56M | 47.29M | 49.38M | 42.43M |
| Total Debt | 916.05K | 895.64K | 1.23M | 1.54M | 2.92M | 4.24M |
| Total Liabilities | 67.50M | 68.26M | 73.55M | 80.38M | 104.21M | 113.98M |
| Stockholders Equity | 70.09M | 74.38M | 87.17M | 99.29M | 106.54M | 99.17M |
Cash Flow | ||||||
| Free Cash Flow | -7.41M | -7.60M | -13.00M | 1.91M | -61.95K | -25.57M |
| Operating Cash Flow | -6.96M | -7.06M | -11.56M | 2.77M | 16.77M | 32.79M |
| Investing Cash Flow | 6.91M | 5.98M | 3.66M | -10.76M | -31.20M | -63.04M |
| Financing Cash Flow | -574.62K | -567.32K | -535.43K | 941.64K | 4.99M | 41.84M |
Retractable Technologies Technical Analysis
Positive
0.73
Price Trends
0.68
Positive
0.68
Positive
0.75
Negative
Market Momentum
<0.01
Negative
53.76
Neutral
73.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RVP, the sentiment is Positive. The current price of 0.73 is above the 20-day moving average (MA) of 0.69, above the 50-day MA of 0.68, and below the 200-day MA of 0.75, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 53.76 is Neutral, neither overbought nor oversold. The STOCH value of 73.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RVP.
Retractable Technologies Risk Analysis
Retractable Technologies disclosed 18 risk factors in its most recent earnings report. Retractable Technologies reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Retractable Technologies Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
54 Neutral | $307.06M | -4.25 | -21.50% | ― | -30.08% | -143.79% | |
53 Neutral | $216.18M | -6.14 | -246.44% | ― | 17.41% | -189.91% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | $21.55M | -3.37 | -8.13% | ― | 10.08% | 71.71% | |
49 Neutral | $168.11M | -7.00 | -153.21% | ― | 13.40% | 20.97% | |
45 Neutral | $28.39M | -5.88 | -166.28% | ― | 3.37% | 15.78% |
* Healthcare Sector Average
RVP
Retractable Technologies
0.72
0.08
12.15%
OSUR
Orasure Technologies
4.46
1.40
45.75%
STXS
Stereotaxis
1.72
-0.44
-20.37%
MLSS
Milestone Scientific
0.32
-0.31
-48.72%
SMTI
Sanara MedTech
23.59
-6.35
-21.21%
Retractable Technologies Corporate Events
Dividends
Retractable Technologies Declares Dividend on Preferred Stock
Positive
Jun 30, 2026
On June 30, 2026, Retractable Technologies announced that its board declared a dividend for holders of its Series II and Series III Class B Convertible Preferred Stock. The move underscores the company’s ongoing capital allocation to preferr...
Financial Disclosures
Retractable Technologies Releases First-Quarter 2026 Financial Results
Neutral
May 15, 2026
Retractable Technologies reported that on May 15, 2026, it released its financial results for the quarter ended March 31, 2026. The announcement formalizes the company’s disclosure of first-quarter performance, providing stakeholders with up...
Executive/Board ChangesShareholder Meetings
Retractable Technologies Shareholders Reelect Class 2 Directors
Positive
May 13, 2026
Retractable Technologies, Inc. held its Annual Meeting of Shareholders as a virtual event on May 8, 2026, where shareholders voted on the election of Class 2 directors. All three Board-nominated Class 2 directors, Thomas J. Shaw, Walter O. Bigby, ...
Business Operations and Strategy
Retractable Technologies Announces Workforce Reduction and Restructuring Plan
Negative
Apr 10, 2026
On April 9, 2026, Retractable Technologies announced it was reducing its workforce, signaling a significant change in the company’s operational structure. The job cuts suggest management is undertaking cost-cutting or restructuring measures ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.